Johns Hopkins University

Running trials

• Not yet recruiting

  Safety Study of XT-150 in Participants With ALS

  NCT06704347· Phase 1· Source

• Not yet recruiting

  Brain Imaging of DSP-2342

  NCT07850102· Phase 2· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Source

• Not yet recruiting

  Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?

  NCT07793097· Source

• Recruiting

  Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

  NCT07438041· Source

• Recruiting

  WATER IV PCa (AS Sub-study)

  NCT07650448· Source

• Recruiting

  PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

  NCT07550517· Phase 2· Source

• Recruiting

  An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

  NCT06996652· Phase 2· Source

• Enrolling by invitation

  Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV

  NCT07461350· Source

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Source

• Recruiting

  Screen2Prevent (S2P)

  NCT07728123· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· Phase 2· Source

• Recruiting

  Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women

  NCT07042386· Source

• Recruiting

  Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  NCT07621718· Phase 3· Source

• Recruiting

  Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

  NCT07226453· Phase 2· Source

• Recruiting

  Precision Radiotherapy Enabled by Molecular MRI

  NCT07512154· Source

• Recruiting

  Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

  NCT07497399· Phase 2· Source

• Recruiting

  A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

  NCT07143968· Phase 2· Source

• Recruiting

  EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  NCT07287670· Phase 2· Source

• Recruiting

  Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  NCT07297979· Phase 1· Source

• Recruiting

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· Phase 3· Source

• Recruiting

  Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity

  NCT07396805· Source

• Recruiting

  Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

  NCT07337590· Source

• Recruiting

  Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  NCT07059091· Phase 2· Source

• Recruiting

  Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

  NCT07389590· Phase 4· Source

• Recruiting

  CF Wellness Program

  NCT07071324· Source

• Recruiting

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· Phase 3· Source

• Recruiting

  Addressing Hypertension Care in Africa Program

  NCT06986590· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

  NCT07227454· Phase 3· Source

• Recruiting

  Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  NCT07195591· Phase 3· Source

• Recruiting

  Exercise in Prostate Cancer

  NCT06165302· Source

• Recruiting

  A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  NCT07008118· Phase 1· Source

• Recruiting

  Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

  NCT06847399· Phase 2· Source

• Recruiting

  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07164443· Phase 3· Source

• Recruiting

  Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

  NCT06188741· Phase 2· Source

• Recruiting

  Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

  NCT06950385· Phase 3· Source

• Recruiting

  Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06995677· Phase 2· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Source

• Recruiting

  A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  NCT07020221· Phase 1/2· Source

• Recruiting

  Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

  NCT05730283· Phase 2· Source

• Recruiting

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· Phase 3· Source

• Recruiting

  Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

  NCT06683092· Source

• Recruiting

  Myofascial Dysfunction in Post Stroke Shoulder Pain

  NCT06718413· Phase 2· Source

• Recruiting

  Embryonal Tumor With Multilayered Rosettes

  NCT06861244· Phase 2· Source

• Recruiting

  Rilonacept in Subjects With Cardiac Sarcoidosis

  NCT06660732· Phase 2· Source

• Recruiting

  SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

  NCT06389097· Source

• Active, not recruiting

  WATER IV Prostate Cancer

  NCT06651632· Source

• Recruiting

  Remote Sputum Collection in Cystic Fibrosis

  NCT06950892· Source

• Recruiting

  RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  NCT06798896· Phase 2· Source

Showing 50 of 173.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers10 recruiting
• Lung cancer9 recruiting
• HIV8 recruiting
• Prostate cancer8 recruiting
• Cystic fibrosis6 recruiting
• Pancreatic cancer6 recruiting
• Heart failure5 recruiting
• Colorectal cancer4 recruiting
• Obesity4 recruiting
• Type 1 diabetes4 recruiting
• ALS (motor neurone disease)3 recruiting
• Head and neck cancer3 recruiting
• High blood pressure3 recruiting
• Huntington's disease3 recruiting
• Macular degeneration3 recruiting
• Multiple sclerosis3 recruiting
• Sarcoma3 recruiting
• Stroke3 recruiting
• Acute myeloid leukaemia2 recruiting
• Alzheimer disease2 recruiting
• Amyloidosis2 recruiting
• Bladder cancer2 recruiting
• Chronic kidney disease2 recruiting
• COPD2 recruiting
• Coronary artery disease2 recruiting
• Endometrial cancer2 recruiting
• Epilepsy2 recruiting
• Frontotemporal dementia2 recruiting
• Glioblastoma2 recruiting
• Melanoma2 recruiting
• Parkinson disease2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Asthma1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Atrial fibrillation1 recruiting
• Cervical cancer1 recruiting
• Crohn's disease1 recruiting
• Depression1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Hodgkin lymphoma1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Ovarian cancer1 recruiting
• Rheumatoid arthritis1 recruiting
• Schizophrenia1 recruiting
• Sickle cell disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  OnTrackCF: Engagement, Feasibility, and Acceptability Study

  NCT07031323· Source

• Terminated

  Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

  NCT06543446· Source

• Completed

  A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

  NCT06159725· Phase 1/2· Source

• Completed

  AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors

  NCT06257550· Source

• Completed

  Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)

  NCT06046170· Source

• Terminated

  Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

  NCT05978804· Source

• Completed

  Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue

  NCT06132386· Source

• Completed

  Health Outcomes of Parents With Cystic Fibrosis

  NCT05829694· Source

• Completed

  Patient Centered Mobile Health Technology Enabled Atrial Fibrillation Management

  NCT05400837· Source

• Recruiting

  A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  NCT05442567· Phase 3· Source

• Terminated

  Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

  NCT05636852· Phase 2· Source

• Completed

  Impact of a Corrie Cardiac Rehabilitation Program

  NCT05238103· Source

• Completed

  Community Active and Healthy Families

  NCT04414553· Source

• Terminated

  RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

  NCT05298358· Phase 1· Source

• Completed

  Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

  NCT05284617· Phase 2· Source

• Completed

  A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

  NCT05453578· Phase 1/2· Source

• Completed

  Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

  NCT05633407· Phase 2· Source

• Completed

  Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

  NCT05383872· Source

• Completed

  A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

  NCT05360680· Phase 1· Source

• Completed

  A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

  NCT05375903· Phase 1· Source

• Completed

  Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

  NCT04965597· Phase 2· Source

• Completed

  MEMORI Corps: Activity-based Companion Care for Dementia

  NCT03896711· Source

• Completed

  COVID-19 Vaccine Response in Sickle Cell Disease

  NCT05139992· Source

• Completed

  Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

  NCT04906447· Phase 2· Source

• Completed

  A Mobile Application to Improve Procurement and Distribution of Healthful Foods & Beverages in Baltimore City

  NCT05010018· Source

• Completed

  HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

  NCT04975698· Phase 2· Source

• Completed

  Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

  NCT04770337· Source

• Completed

  Afrezza® INHALE-1 Study in Pediatrics

  NCT04974528· Phase 3· Source

• Completed

  Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

  NCT04936308· Phase 3· Source

• Completed

  PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

  NCT04815876· Source

• Completed

  COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

  NCT04958889· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Source

• Completed

  Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

  NCT04884308· Phase 2· Source

• Completed

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Source

• Recruiting

  A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  NCT04786262· Phase 3· Source

• Completed

  PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy

  NCT04843566· Source

• Completed

  A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

  NCT04585789· Phase 2· Source

• Completed

  Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

  NCT04440592· Phase 2· Source

• Terminated

  PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT04524195· Phase 1· Source

• Completed

  A Communication Tool to Assist Older Adults Facing Dialysis Choices

  NCT04466865· Source

• Terminated

  Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

  NCT04583488· Phase 1· Source

• Completed

  Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis

  NCT04261790· Phase 4· Source

• Completed

  Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

  NCT04381832· Phase 1/2· Source

• Completed

  Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

  NCT04495556· Source

• Completed

  Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

  NCT04084080· Phase 3· Source

• Completed

  Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children

  NCT04260048· Source

• Completed

  EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression

  NCT04266431· Source

• Completed

  Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

  NCT04069312· Phase 3· Source

• Completed

  Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)

  NCT04197336· Source

• Completed

  iCLAS™ for Persistent Atrial Fibrillation

  NCT04061603· Source

Showing 50 of 83.